Effects of the Vasopeptidase Inhibitor, Omapatrilat, in 723 Patients With Coronary Heart Disease

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System - United Kingdom
doi 10.3317/jraas.2002.049
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Cardiac and Renal Effects of Omapatrilat, a Vasopeptidase Inhibitor, in Rats With Experimental Congestive Heart Failure

American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular MedicinePhysiologyCardiology
2004English

Haemodynamic Effects of Intravenous Cibenzoline in Patients With Coronary Heart Disease

European Journal of Clinical Pharmacology
MedicinePharmacology
1984English

Effects of Psychoeducation on Mental Health in Patients With Coronary Heart Disease

Iranian Red Crescent Medical Journal
Medicine
2016English

The Antithrombotic Therapy of Atrial Fibrillation in Patients With Coronary Heart Disease

Russian Open Medical Journal
Medicine
2018English

AB0602 Antiphospholipid Syndrome Components in Patients With Coronary Heart Disease

2018English

Telomer Length in Patients of Different Age With Coronary Heart Disease

The Bulletin of Contemporary Clinical Medicine
2018English

The Association Between Sortilin and Inflammation in Patients With Coronary Heart Disease

Journal of Inflammation Research
AllergyImmunology
2020English

Preoperative Prediction of Significant Coronary Artery Disease in Patients With Valvular Heart Disease.

BMJ
1982English

Effects of Propranolol Therapy on Platelet Release and Prostaglandin Generation in Patients With Coronary Heart Disease

Circulation
Cardiovascular MedicinePhysiologyCardiology
1982English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy